Noble Wealth Management PBC Invests $134,000 in The Clorox Company (NYSE:CLX)

Noble Wealth Management PBC acquired a new position in The Clorox Company (NYSE:CLX) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 828 shares of the company’s stock, valued at approximately $134,000.

Several other large investors have also recently bought and sold shares of CLX. Integral Investment Advisors Inc. increased its holdings in Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock valued at $279,000 after purchasing an additional 67 shares during the last quarter. HCR Wealth Advisors grew its position in shares of Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after buying an additional 68 shares during the period. Empower Advisory Group LLC increased its stake in shares of Clorox by 4.5% in the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after acquiring an additional 78 shares during the last quarter. Aviance Capital Partners LLC raised its position in shares of Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after acquiring an additional 80 shares during the period. Finally, Lindbrook Capital LLC boosted its stake in Clorox by 9.9% during the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after acquiring an additional 88 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 1.4 %

NYSE:CLX opened at $156.52 on Friday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a market cap of $19.28 billion, a P/E ratio of 42.76, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The business has a 50 day moving average price of $156.88 and a two-hundred day moving average price of $160.26.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company posted $2.16 EPS. As a group, analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.12%. Clorox’s payout ratio is presently 133.33%.

Analyst Upgrades and Downgrades

Several brokerages have commented on CLX. Evercore ISI upped their target price on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Wells Fargo & Company boosted their target price on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, JPMorgan Chase & Co. lifted their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.